Occurrence of rpoB mutations in isoniazid-Resistant but rifampin-Susceptible mycobacterium tuberculosis isolates from germany

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 1, 2014, Pages 590-592

  Andres, Sönke ^a   Hillemann, Doris ^a   Rüsch Gerdes, Sabine ^a   Richter, Elvira ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; GENE MUTATION; GERMANY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; GERMANY; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN;

EID: 84891513914     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01752-13     Document Type: Article

References (21)

1. Zhang Y, Yew WW. 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 13:1320-1330
2. Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Rigouts L, Rüsch-Gerdes S, Wright A. 2009. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J. Clin. Microbiol. 47:3501-3506. http://dx.doi.org/10.1128/JCM.01209-09.
3. Drobniewski F, Nikolayevskyy V, Balabanova Y, Bang D, Papaventsis D. 2012. Diagnosis of tuberculosis and drug resistance: What can new tools bring us? Int. J. Tuberc. Lung Dis. 16:860-870. http://dx.doi.org/10.5588/ijtld.12. 0180.
4. Hillemann D, Rüsch-Gerdes S, Richter E. 2007. Evaluation of the Geno- Type MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640. http://dx.doi.org/10.1128/JCM.00521-07.
5. Hillemann D, Richter E, Rüsch-Gerdes S. 2006. Use of the BACTEC Mycobacteria Growth Indicator Tube 960 automated system for recovery of mycobacteria from 9,558 extrapulmonary specimens, including urine samples. J. Clin. Microbiol. 44:4014-4017. http://dx.doi.org/10.1128/JCM.00829-06.
6. Telenti A, Honoré N, Bernasconi C, March J, Ortega A, Heym B, Takiff HE, Cole ST. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723.
7. Williamson DA, Roberts SA, Bower JE, Vaughan R, Newton S, Lowe O, Lewis CA, Freeman JT. 2012. Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 16:216-220. http://dx.doi.org/10.5588/ijtld.11.0178.
8. Ho J, Jelfs P, Sintchencko V. 2013. Phenotypically occult multidrugresistant Mycobacterium tuberculosis: Dilemmas in diagnosis and treatment. J. Antimicrob. Chemother. 68:2915-2920. http://dx.doi.org/10.1093/ jac/dkt284.
9. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB. 2009. Tuberculosis drug resistance mutation database. PLoS Med. 6:e1000002. http://dx.doi.org/10.1371/journal.pmed.1000002.
10. Chan RCY, Hui M, Chan EWC, Au TK, Chin ML, Yip CK, AuYeang CKW, Yeung CYL, Kam KM, Yip PCW, Cheng AFB. 2007. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J. Antimicrob. Chemother. 59:866-873. http://dx.doi.org/10.1093/jac/dkm054.
11. Sajduda A, Brzostek A, Poplawska M, Augustynowicz-Kopec E, Zwolska Z, Niemann S, Dziadek J, Hillemann D. 2004. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J. Clin. Microbiol. 42:2425-2431. http://dx.doi.org/10.1128/JCM.42.6.2425-2431. 2004.
12. Fenner L, Egger M, Bodmer T, Altpeter E, Zwahlen M, Jaton K, Pfyffer GE, Borrell S, Dubuis O, Bruderer T, Siegrist HH, Furrer H, Calmy A, Fehr J, Stalder JM, Ninet B, Böttger EC, Gagneux S. 2012. Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56:3047-3053. http://dx doi.org/10.1128/AAC.06460-11
13. Feuerriegel S, Oberhauser B, George AG, Dafae F, Richter E, Rüsch-Gerdes S, Niemann S. 2012. Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a highincidence setting. BMC Microbiol. 12:90. http://dx.doi.org/10.1186/1471- 2180-12-90.
14. Traore H, Ogwang S, Mallard K, Joloba ML, Mumbowa F, Narayan K, Kayes S, Jones-Lopez EC, Smith PG, Ellner JJ, Mugerwa RD, Eisenach KD, McNerney R. 2007. Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Ann. Clin. Microbiol. Antimicrob. 6:1. http://dx.doi.org/10.1186/1476-0711-6-1.
15. Ohno H, Koga H, Kohno S, Tashiro T, Hara K. 1996. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40:1053-1056.
16. Hillemann D, Kubica T, Rüsch-Gerdes S, Niemann S. 2005. Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany. Antimicrob. Agents Chemother. 49:1229-1231. http://dx.doi.org/10.1128/AAC.49.3. 1229-1231.2005.
17. Huitric E, Werngren J, Juréen P, Hoffner S. 2006. Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants. Antimicrob. Agents Chemother. 50: 2860-2862. http://dx.doi.org/10.1128/AAC.00303-06.
18. Deutsche Institut für Normung E. V. 2009. DIN 58943-8, Medical microbiology-diagnosis of tuberculosis. Part 8: Methods for the determination of susceptibility of tubercle bacilli to chemotherapeutic agents.
19. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. World Health Organ. 41:21-43.
20. Rigouts L, Gumusboga M, de Rijk WB, Nduwamahoro E, Uwizeye C, de Jong B, Deun AV. 2013. Rifampicin resistance missed in automated liquid culture system for Mycobacterium tuberculosis with specific rpoB mutations. J. Clin. Microbiol. 51:2641-2645. http://dx.doi.org/10.1128/JCM.02741-12.
21. Van Deun A, Aung KJM, Bola V, Lebeke R, Hossain MA, de Rijk WB, Rigouts L, Gumusboga A, Torrea G, de Jong BC. 2013. Rifampin drug resistance tests for tuberculosis: Challenging the gold standard. J. Clin. Microbiol. 51:2633-2640. http://dx.doi.org/10.1128/JCM.00553-13